United Kingdom

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

20 Apr 2018
Change (% chg)

$-21.66 (-12.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Kevin Starr

54 2016 Independent Chairman of the Board

Jeffrey Jonas

64 2013 President, Chief Executive Officer, Director

Kimi Iguchi

53 2016 Chief Financial Officer, Treasurer

Anne Cook

54 2016 Senior Vice President, General Counsel

Amy Schacterle

2017 Senior Vice President - Regulatory Affairs and Quality Assurance